These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10838498)

  • 21. Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD.
    Friday BB; Mitchell PO; Kegley KM; Pavlath GK
    Differentiation; 2003 Apr; 71(3):217-27. PubMed ID: 12694204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in the methylation profile and structure of Pax3 and Pax7 among different mouse strains and during expression.
    Kay PH; Harmon D; Fletcher S; Ziman M; Jacobsen PF; Papadimitriou JM
    Gene; 1997 Jan; 184(1):45-53. PubMed ID: 9016952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
    Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
    Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
    Keller C; Hansen MS; Coffin CM; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
    Dias P; Chen B; Dilday B; Palmer H; Hosoi H; Singh S; Wu C; Li X; Thompson J; Parham D; Qualman S; Houghton P
    Am J Pathol; 2000 Feb; 156(2):399-408. PubMed ID: 10666368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma.
    Weber-Hall S; McManus A; Anderson J; Nojima T; Abe S; Pritchard-Jones K; Shipley J
    Genes Chromosomes Cancer; 1996 Sep; 17(1):7-13. PubMed ID: 8889501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
    Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
    Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma.
    Du S; Lawrence EJ; Strzelecki D; Rajput P; Xia SJ; Gottesman DM; Barr FG
    Int J Cancer; 2005 May; 115(1):85-92. PubMed ID: 15688409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
    Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
    Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Ahn EH
    Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
    Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
    Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.
    Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM
    Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. POU homeodomain genes and myogenesis.
    Dominov JA; Miller JB
    Dev Genet; 1996; 19(2):108-18. PubMed ID: 8900043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription of MyoD and myogenin in the non-contractile electrogenic cells of the weakly electric fish, Sternopygus macrurus.
    Kim JA; Jonsson CB; Calderone T; Unguez GA
    Dev Genes Evol; 2004 Aug; 214(8):380-92. PubMed ID: 15309633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
    Davis RJ; D'Cruz CM; Lovell MA; Biegel JA; Barr FG
    Cancer Res; 1994 Jun; 54(11):2869-72. PubMed ID: 8187070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin of patterning in neural tubes.
    Wada H; Holland PW; Satoh N
    Nature; 1996 Nov; 384(6605):123. PubMed ID: 8906785
    [No Abstract]   [Full Text] [Related]  

  • 39. Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma?
    Foschini MP; Eusebi V
    Semin Diagn Pathol; 1994 Feb; 11(1):58-68. PubMed ID: 8202647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of skeletal muscle-specific transcription: involvement of paired homeodomain and MADS domain transcription factors.
    Duprey P; Lesens C
    Int J Dev Biol; 1994 Dec; 38(4):591-604. PubMed ID: 7779681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.